What MRD Testing Can Mean for Patients With Breast Cancer and SurvivorsByDr. Pablo PrichardFebruary 1st 2026
Ibrance Adds 15 Months of Progression-Free Survival in HR+, HER2+ Breast CancerByCURE staffJanuary 30th 2026
The Last Walk Down the Hall: Reflections Before Entering Cancer SurvivorshipByBonnie AnnisJanuary 30th 2026
Biotin, Lab Interference and Safer Options for Cancer-Related Hair Loss ByRyan ScottJanuary 30th 2026